150 related articles for article (PubMed ID: 22561558)
1. CYP1B1 and hormone-induced cancer.
Gajjar K; Martin-Hirsch PL; Martin FL
Cancer Lett; 2012 Nov; 324(1):13-30. PubMed ID: 22561558
[TBL] [Abstract][Full Text] [Related]
2. Cytochrome P450 1B1 and catechol-O-methyltransferase polymorphisms and endometrial cancer susceptibility.
McGrath M; Hankinson SE; Arbeitman L; Colditz GA; Hunter DJ; De Vivo I
Carcinogenesis; 2004 Apr; 25(4):559-65. PubMed ID: 14656940
[TBL] [Abstract][Full Text] [Related]
3. Pharmacogenetics and regulation of human cytochrome P450 1B1: implications in hormone-mediated tumor metabolism and a novel target for therapeutic intervention.
Sissung TM; Price DK; Sparreboom A; Figg WD
Mol Cancer Res; 2006 Mar; 4(3):135-50. PubMed ID: 16547151
[TBL] [Abstract][Full Text] [Related]
4. Cytochrome P450 1B1 gene polymorphisms and postmenopausal breast cancer risk.
Rylander-Rudqvist T; Wedren S; Granath F; Humphreys K; Ahlberg S; Weiderpass E; Oscarson M; Ingelman-Sundberg M; Persson I
Carcinogenesis; 2003 Sep; 24(9):1533-9. PubMed ID: 12844487
[TBL] [Abstract][Full Text] [Related]
5. CYP1B1 gene in endometrial cancer.
Sasaki M; Kaneuchi M; Fujimoto S; Tanaka Y; Dahiya R
Mol Cell Endocrinol; 2003 Apr; 202(1-2):171-6. PubMed ID: 12770747
[TBL] [Abstract][Full Text] [Related]
6. Cytochrome P450 1B1 gene polymorphisms and postmenopausal endometrial cancer risk.
Rylander-Rudqvist T; Wedrén S; Jonasdottir G; Ahlberg S; Weiderpass E; Persson I; Ingelman-Sundberg M
Cancer Epidemiol Biomarkers Prev; 2004 Sep; 13(9):1515-20. PubMed ID: 15342454
[TBL] [Abstract][Full Text] [Related]
7. [Polymorphisms of CYP1B1 and COMT in breast and endometrial cancer].
Zimarina TC; Kristensen VN; Imianitov EN; Bershteĭn LM
Mol Biol (Mosk); 2004; 38(3):386-93. PubMed ID: 15285606
[TBL] [Abstract][Full Text] [Related]
8. Cytochrome P450 CYP1B1 and catechol O-methyltransferase (COMT) genetic polymorphisms and breast cancer susceptibility in a Turkish population.
Kocabaş NA; Sardaş S; Cholerton S; Daly AK; Karakaya AE
Arch Toxicol; 2002 Nov; 76(11):643-9. PubMed ID: 12415427
[TBL] [Abstract][Full Text] [Related]
9. Functional significance of cytochrome P450 1B1 in endometrial carcinogenesis.
Saini S; Hirata H; Majid S; Dahiya R
Cancer Res; 2009 Sep; 69(17):7038-45. PubMed ID: 19690133
[TBL] [Abstract][Full Text] [Related]
10. Genetic polymorphisms in catalase and CYP1B1 determine DNA adduct formation by benzo(a)pyrene ex vivo.
Schults MA; Chiu RK; Nagle PW; Wilms LC; Kleinjans JC; van Schooten FJ; Godschalk RW
Mutagenesis; 2013 Mar; 28(2):181-5. PubMed ID: 23325794
[TBL] [Abstract][Full Text] [Related]
11. Case-control study of ovarian cancer and polymorphisms in genes involved in catecholestrogen formation and metabolism.
Goodman MT; McDuffie K; Kolonel LN; Terada K; Donlon TA; Wilkens LR; Guo C; Le Marchand L
Cancer Epidemiol Biomarkers Prev; 2001 Mar; 10(3):209-16. PubMed ID: 11303589
[TBL] [Abstract][Full Text] [Related]
12. Cytochrome P1B1 (CYP1B1) polymorphisms and ovarian cancer risk: a meta-analysis.
Gajjar K; Owens G; Sperrin M; Martin-Hirsch PL; Martin FL
Toxicology; 2012 Dec; 302(2-3):157-62. PubMed ID: 23032576
[TBL] [Abstract][Full Text] [Related]
13. Cytochrome P450 1B1 is overexpressed and regulated by hypomethylation in prostate cancer.
Tokizane T; Shiina H; Igawa M; Enokida H; Urakami S; Kawakami T; Ogishima T; Okino ST; Li LC; Tanaka Y; Nonomura N; Okuyama A; Dahiya R
Clin Cancer Res; 2005 Aug; 11(16):5793-801. PubMed ID: 16115918
[TBL] [Abstract][Full Text] [Related]
14. Three polymorphisms in cytochrome P450 1B1 (CYP1B1) gene and breast cancer risk: a meta-analysis.
Economopoulos KP; Sergentanis TN
Breast Cancer Res Treat; 2010 Jul; 122(2):545-51. PubMed ID: 20054638
[TBL] [Abstract][Full Text] [Related]
15. Cytochrome P450 1B1, a new keystone in gene-environment interactions related to human head and neck cancer?
Thier R; Brüning T; Roos PH; Bolt HM
Arch Toxicol; 2002 Jun; 76(5-6):249-56. PubMed ID: 12107641
[TBL] [Abstract][Full Text] [Related]
16. Expression of cytochrome P450 1B1 and catechol-O-methyltransferase in breast tissue and their associations with breast cancer risk.
Wen W; Ren Z; Shu XO; Cai Q; Ye C; Gao YT; Zheng W
Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):917-20. PubMed ID: 17507616
[TBL] [Abstract][Full Text] [Related]
17. Association of CYP1B1 genetic polymorphism with incidence to breast and lung cancer.
Watanabe J; Shimada T; Gillam EM; Ikuta T; Suemasu K; Higashi Y; Gotoh O; Kawajiri K
Pharmacogenetics; 2000 Feb; 10(1):25-33. PubMed ID: 10739169
[TBL] [Abstract][Full Text] [Related]
18. Cytochrome P450 1B1 (CYP1B1) pharmacogenetics: association of polymorphisms with functional differences in estrogen hydroxylation activity.
Hanna IH; Dawling S; Roodi N; Guengerich FP; Parl FF
Cancer Res; 2000 Jul; 60(13):3440-4. PubMed ID: 10910054
[TBL] [Abstract][Full Text] [Related]
19. Disturbed expression of phase I and phase II estrogen-metabolizing enzymes in endometrial cancer: lower levels of CYP1B1 and increased expression of S-COMT.
Hevir N; Sinkovec J; Rižner TL
Mol Cell Endocrinol; 2011 Jan; 331(1):158-67. PubMed ID: 20887769
[TBL] [Abstract][Full Text] [Related]
20. Elevated expression of CYP1A1 and gamma-SYNUCLEIN in human ectopic (ovarian) endometriosis compared with eutopic endometrium.
Singh MN; Stringfellow HF; Taylor SE; Ashton KM; Ahmad M; Abdo KR; El-Agnaf OM; Martin-Hirsch PL; Martin FL
Mol Hum Reprod; 2008 Nov; 14(11):655-63. PubMed ID: 18849443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
